I'm not sure how you have come to the conclusion that I have implied that a failed test, here or there, marks the end for the company. On the contrary. I would expect that from a pharmaceutical in the development stages - but it is precisely the lack of ANY such negative information that is my concern.
My previous post suggested that I see no evidence (yet) of tangible progress, beyond minor, selective, lab releases, toward the original concept of a sepsis treatment that is effective AND safe to use at human level. Others can infer whatever they like from the available information, but that is my view. It is further bolstered by the way the company has been easily distracted from it's core objective by darting to other fields, such as Covid treatments, etc. If you have faith in your primary objective, you do not need, or want, distractions of this kind.
Of course, when you have access to a truckload of other people's money, you can afford to play at the roulette table.
Wold, I don't "keep alluding" to my previous history and "inside information", posters KEEP ASKING for it - I know what I know and what I post are my personal views and opinions. You, and others, can engage in that discussion, or ignore it. There is no mystery here and my motives are nothing more than sharing information with those who are interested to hear it - those that aren't can look away and do their own thing.
A bit like when a child is told "look both ways before crossing the street".
RCE Price at posting:
97.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)